Receiving anti VEGF eye injections around the time of a stroke or heart attack is not linked to an increased risk for death or major complications, a study finds. Medscape Medical News
Drug Farm Announces U.S. FDA Orphan Drug Designation for DF-003 for the Treatment of ROSAH Syndrome
ALBANY, N.Y. & SHANGHAI–(BUSINESS WIRE)–Drug Farm today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to DF-003, the company’s investigational small molecule inhibitor targeting ALPK1, for the tr…
Kodiak Sciences Eye Drug Succeeds in Late-stage Study
Kodiak Sciences’ experimental drug met the main goal in a late-stage trial. Reuters Health Information
Global deaths from early-onset cancer fall significantly
Early-onset cancer incidence increased 3% globally during the past 3 decades, but mortality from these malignancies dropped 17%.“It’s good news,” Rupayan Kundu, MD, resident physician at Cleveland Clinic, told Healio, comparing the “subtle” increase in…
White House delays picking CDC director despite deadline
The White House did not nominate a new CDC director on Wednesday despite coming up against a federally imposed deadline to do so.White House spokesperson Kush Desai told Healio that NIH Director Jay Bhattacharya, MD, PhD, will continue to perform the d…
Elios system reduces IOP in open-angle glaucoma
Editor’s note: This is a developing news story. Please check back soon for updates.In a pivotal clinical trial, an excimer laser procedure reduced IOP in patients with glaucoma, according to a press release from Bausch + Lomb.The Elios system reduced p…